CRL logo

CRL
Charles River Laboratories International Inc.

912
Mkt Cap
$7.72B
Volume
588,606.00
52W High
$228.88
52W Low
$132.58
PE Ratio
-42.63
CRL Fundamentals
Price
$160.30
Prev Close
$158.86
Open
$159.83
50D MA
$167.76
Beta
1.44
Avg. Volume
795,320.62
EPS (Annual)
-$2.91
P/B
2.63
Rev/Employee
$203,826.50
$12,557.80
Loading...
Loading...
News
all
press releases
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
News Placeholder
More News
News Placeholder
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well...
News Placeholder
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
News Placeholder
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly...
News Placeholder
Charles River Laboratories International Q1 Earnings Call Highlights
Charles River Laboratories International Q1 Earnings Call Highlights...
News Placeholder
LH vs. CRL: Which Stock Is the Better Value Option?
LH vs. CRL: Which Stock Is the Better Value Option?
News Placeholder
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. Analysts maintain positive outlook with raised price targets.read more...
News Placeholder
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
Charles River beats Q1 earnings and revenue estimates, but margin declines and weak organic growth in key segments send shares lower in pre-market.
News Placeholder
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
News Placeholder
Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates
Charles River (CRL) delivered earnings and revenue surprises of +5.24% and +2.55%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available